Bill · S. 1784· Senate(119-S-1784)
MAPS Act
- Introduced
- 5/15/2025
- Last activity
- 3/19/2026 — Committee on Health, Education, Labor, and Pensions. Hearings held.
- Sponsored by
- Gary Peters
- Cosponsors
- - 2 - 4
- Introduced
- In Committee
What this bill would do
The MAPS Act aims to improve how the Federal government identifies and handles health and national security risks regarding medicine. The bill requires the Secretary of Health and Human Services to maintain an "Essential Medicines List" that includes drugs critical for medical priority, chronic conditions, or military preparedness. It mandates a comprehensive risk assessment of the supply chains for these medicines to identify vulnerabilities. Additionally, the Act directs the creation of a system to map pharmaceutical supply chains using data analytics. The Secretary of Defense is also required to report on drugs purchased by the Department of Defense that involve sourcing or manufacturing in the People's Republic of China.
Yes· 3 of 6
Does this make the country readier for the next outbreak?+5
The bill enhances preparedness by identifying essential medicines and their supply chain vulnerabilities.
Does this better protect the country from computer attacks?+5
The bill requires assessments of cybersecurity threats to pharmaceutical supply chains.
Does this make health care easier to get in general?+4
By mapping and mitigating supply chain risks, the bill helps ensure continuous access to essential medicines.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Protection against shortages: The creation of an Essential Medicines List includes drugs of "greatest priority for providing health care" and those "at high risk of shortage," which helps address needs for patients with chronic conditions (Section 2(a)).
-
Improved national security: The bill mandates a risk assessment to identify "public health and national security risks, including cybersecurity threats" related to drug supply chains (Section 3(b)(5)).
-
Mitigation of supply chain risks: The Secretary is tasked with determining how the Federal Government will mitigate national security risks, including through the use of "authorities under the Defense Production Act of 1950" (Section 3(b)(7)).
-
Enhanced supply chain visibility: The Act seeks to "map, or otherwise visualize, the supply chains" from raw materials to finished drugs, which can help identify vulnerabilities (Section 4(a)(1)).
Potential Negative Impacts for People
- No specific negative impacts are explicitly stated in the text regarding burdens on individuals or groups.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Pandemic Preparedness+5Improves Healthcare Access+4
- Governance And Ideology
- Improves Government Transparency+4Increases Federal Power+3
- National Security And Foreign Policy
- Improves Cybersecurity Defense+5
- Economy And Finance
- Improves Consumer Protection+3
- 3/19/2026
- Committee on Health, Education, Labor, and Pensions. Hearings held.
- 11/7/2025
- 1 Cosponsor added.
- 5/15/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 6 Cosponsors added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Tom CottonRepublican · Arkansas
Joni ErnstRepublican · Iowa
Angus KingIndependent · Maine
Timothy KaineDemocrat · Virginia
James LankfordRepublican · Oklahoma
Elissa SlotkinDemocrat · Michigan
Rick ScottRepublican · Florida